tiprankstipranks
Trending News
More News >
Abbvie (ABBV)
NYSE:ABBV
US Market

AbbVie (ABBV) Drug Pipeline

Compare
23,415 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Abbv-444, Refresh Optive Ud
Dry Eye Disease
Phase III
Recruiting
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
Dec 08, 2025
Epcoritamab, Investigator's Choice Chemotherapy
Diffuse Large B-Cell Lymphoma
Phase III
Active Not Recruiting
A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) in China
Nov 06, 2025
Abbv-1042
Healthy Volunteer
Phase I
Recruiting
A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants
Oct 29, 2025
Emraclidine
Healthy Volunteer
Phase I
Recruiting
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
Oct 17, 2025
Abbv-1354
Healthy Volunteer
Phase I
Recruiting
A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants
Oct 17, 2025
Elapr002f Injectable Gel, Saline Control
Acne Scars
Phase III
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Oct 02, 2025
Abbv-932
Bipolar I Or Ii Disorder
Phase II
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
Sep 26, 2025
Telisotuzumab Adizutecan
Solid Tumors Harboring Met Amplification
Phase II
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Sep 22, 2025
Juvéderm Volux Xc, Juvéderm Voluma Xc, Juvéderm Volbella Xc, Juvéderm Vollure Xc, Skinvive By Juvéderm, Juvéderm Ultra Xc, Juvéderm Ultra Plus Xc
Mid Face Volume Deficit
Phase IV
Recruiting
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance
Sep 16, 2025
Telisotuzumab Adizutecan, Standard of Care
Non-small Cell Lung Cancer
Phase II/III
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Aug 28, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Abbvie (ABBV) have in its pipeline
      ABBV is currently developing the following drugs: Abbv-444, Refresh Optive Ud, Epcoritamab, Investigator's Choice Chemotherapy, Abbv-1042. These drug candidates are in various stages of clinical development as the company works toward FDA approval.